AADI Aadi Bioscience Inc

USD 1.55 0.00 0
Icon

Aadi Bioscience Inc (AADI) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.55

0.00 (0.00)%

USD 0.04B

0.10M

N/A

USD 19.50 (+1158.06%)

Icon

AADI

Aadi Bioscience Inc (USD)
COMMON STOCK | NSD
USD 1.55
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.04B

USD 19.50 (+1158.06%)

USD 1.55

Aadi Bioscience Inc (AADI) Stock Forecast

N/A

Based on the Aadi Bioscience Inc stock forecast from 0 analysts, the average analyst target price for Aadi Bioscience Inc is not available over the next 12 months. Aadi Bioscience Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aadi Bioscience Inc is Slightly Bearish, which is based on 4 positive signals and 7 negative signals. At the last closing, Aadi Bioscience Inc’s stock price was USD 1.55. Aadi Bioscience Inc’s stock price has changed by +16.54% over the past week, -8.28% over the past month and -73.00% over the last year.

No recent analyst target price found for Aadi Bioscience Inc
No recent average analyst rating found for Aadi Bioscience Inc

Company Overview Aadi Bioscience Inc

Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles ...Read More

https://aadibio.com

17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272

75

December

USD

USA

Adjusted Closing Price for Aadi Bioscience Inc (AADI)

Loading...

Unadjusted Closing Price for Aadi Bioscience Inc (AADI)

Loading...

Share Trading Volume for Aadi Bioscience Inc Shares

Loading...

Compare Performance of Aadi Bioscience Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AADI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Aadi Bioscience Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing AADI

Symbol Name AADI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Aadi Bioscience Inc (AADI) Stock

Stock Target Advisor's fundamental analysis for Aadi Bioscience Inc's stock is Slightly Bearish.

Unfortunately we do not have enough data on AADI's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on AADI's stock to indicate what its average analyst target is.

AADI stock's Price/Earning ratio is 1.58. Our analysis grades AADI stock's Price / Earning ratio at D. This means that AADI stock's Price/Earning ratio is above 35% of the stocks in the Biotechnology sector in the NSD exchange. Based on this AADI may be fairly valued for its sector

The last closing price of AADI's stock was USD 1.55.

The most recent market capitalization for AADI is USD 0.04B.

Unfortunately we do not have enough analyst data on AADI's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Aadi Bioscience Inc's stock.

As per our most recent records Aadi Bioscience Inc has 75 Employees.

Aadi Bioscience Inc's registered address is 17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272. You can get more information about it from Aadi Bioscience Inc's website at https://aadibio.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...